Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

1990 • 1,618 citations

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1990 • 1,294 citations

Anticardiolipin syndrome

2011 • 852 citations

Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

1989 • 637 citations

Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia

1986 • 554 citations

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

1983 • 518 citations

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

1991 • 464 citations

SYNDROME OF THE BLACK SWAN

1987 • 404 citations

Primary Antiphospholipid Syndrome

2020 • 354 citations

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss

1990 • 320 citations

Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant

1984 • 312 citations

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).

1992 • 297 citations

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1989 • 267 citations

Lupus anticoagulant in pregnancy

1984 • 224 citations

Effect of Lupus Anticoagulant on Antithrombogenic Properties of Endothelial Cells - Inhibition of Thrombomodulin-Dependent Protein C Activation

1988 • 194 citations

Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant

1989 • 178 citations

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.

1993 • 133 citations

An IgM Lupus Anticoagulant that Neutralizes the Enhancing Effect of Phospholipid on Purified Endothelial Thrombomodulin Activity-A Mechanism for Thrombosis

1986 • 130 citations

Association of Quantitative Anticardiolipin Antibody Levels with Fetal Loss and Time of Loss in Systemic Lupus Erythematosus

1988 • 93 citations

Immunologic Disease and Fetal Death

1987 • 66 citations

Autoimmune MRL-1 pr/1pr mice are an animal model for the secondary antiphospholipid syndrome.

1990 • 63 citations

Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times

1990 • 50 citations

Continuous Quantitative Monitoring of Mural, Platelet-Dependent, Thrombus Kinetics in the Crushed Rat Femoral Vein

1991 • 45 citations

Inhibition of phospholipid and platelet‐dependent prothrombinase activity in the plasma of patients with lupus anticoagulants

1989 • 31 citations

Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: Characterization and the induction of a secondary antiphospholipid syndrome

1993 • 27 citations

Assays for Phospholipid-Dependent Formation of Thrombin and Xa: A Potential Method for Quantifying Lupus Anticoagulant Activity

1991 • 21 citations